Device type · MID
System, Test, Anticardiolipin Immunological
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MID
Immunology
Device class
Class II
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- System, Test, Anticardiolipin Immunological
- Product code
- MID
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5660
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for MID
Latest FDA decisions
K223093 · Decided Dec 17, 2024 · 809 days after receipt
Device type: System, Test, Anticardiolipin Immunological (MID) · Laboratory Medicine & Pathology
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- BioPlex 2200 REF 665-2050, APLS IgM Pack, APLS IgM Reagent PackOpen, Classified
Z-1572-2023 · Started Feb 28, 2023 · Posted by FDA May 10, 2023
Reason given: APLS IgM reagent kits were packaged with the incorrect conjugate, which could lead to an increase in false-positive and false-negative results.
Cause as FDA categorized it: Under Investigation by firm
Z-2920-2018 · Started Oct 21, 2016 · Posted by FDA Aug 23, 2018
Reason given: Incorrectly labeled Manufactured by DiaSorin, The correct term should be Distributed by DiaSorin.
Cause as FDA categorized it: Error in labeling
Z-2921-2018 · Started Oct 21, 2016 · Posted by FDA Aug 23, 2018
Reason given: Incorrectly labeled Manufactured by DiaSorin, The correct term should be Distributed by DiaSorin.
Cause as FDA categorized it: Error in labeling
14 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.